摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-4-(tert-butyldimethylsilyloxy)butanoic acid

中文名称
——
中文别名
——
英文名称
2-amino-4-(tert-butyldimethylsilyloxy)butanoic acid
英文别名
O-(tert-Butyldimethylsilyl)-L-homoserine;2-amino-4-[tert-butyl(dimethyl)silyl]oxybutanoic acid
2-amino-4-(tert-butyldimethylsilyloxy)butanoic acid化学式
CAS
——
化学式
C10H23NO3Si
mdl
——
分子量
233.383
InChiKey
BKFGDICOIJEWPX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.81
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.9
  • 拓扑面积:
    72.6
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-amino-4-(tert-butyldimethylsilyloxy)butanoic acidtris(dibenzylideneacetone)dipalladium(0) chloroform complex草酰氯 、 sodium hydride 、 caesium carbonate三(邻甲基苯基)磷 作用下, 以 四氢呋喃甲醇二氯甲烷N,N-二甲基甲酰胺甲苯 为溶剂, 反应 37.0h, 生成 6-[2-[(tert-butyldimethylsilyl)oxy]ethyl]-1-[(4-chlorophenyl)methyl]-4,7-dimethyl-2-[3-(trifluoromethoxy)phenoxy]-1H,4H,5H,6H,7H,8H-imidazo[4,5-e][1,4]diazepine-5,8-dione
    参考文献:
    名称:
    WO2019173327A5
    摘要:
    公开号:
    WO2019173327A5
  • 作为产物:
    描述:
    DL-高丝氨酸叔丁基二甲基氯硅烷1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下, 以 乙腈 为溶剂, 以88%的产率得到2-amino-4-(tert-butyldimethylsilyloxy)butanoic acid
    参考文献:
    名称:
    Stereoselective synthesis of 2,4,5-trisubstituted piperidines by carbonyl ene and Prins cyclisations
    摘要:
    报告了一种合成2,4,5-三取代哌啶的方法,其中关键步骤是醛类化合物1的Prins或羰基烯环化反应。在-78°C下,采用浓盐酸催化的CH2Cl2中进行的Prins环化反应,获得了四种可能的立体异构体中的两种良好产率,其中4,5-顺式产物7的产率在立体异构体比率上高达94:6。随着2-取代基体积的增大,环化反应的立体选择性降低,对于体积非常大的2-取代基体则变得无选择性。相比之下,在20–60°C的CH2Cl2或CHCl3中,MeAlCl2催化的环化反应则偏向于4,5-反式立体异构体8,其立体异构体比率高达99:1。由HCl催化的低温环化反应在动力学控制下进行,机制涉及显著的碳正离子特性,其中,4,5-顺式阳离子由于与相邻氧的重叠而比4,5-反式阳离子更稳定。而由MeAlCl2催化的环化反应则在热力学控制下进行,生成的产物中4-和5-取代基均为赤面配置。
    DOI:
    10.1039/b808644c
点击查看最新优质反应信息

文献信息

  • Synthesis of Oxazolidin-2-ones and Imidazolidin-2-ones Directly from 1,3-Diols or 3-Amino Alcohols using Iodobenzene Dichloride and Sodium Azide
    作者:Tian He、Wen-Chao Gao、Wei-Kun Wang、Chi Zhang
    DOI:10.1002/adsc.201300982
    日期:2014.3.24
    A general and efficient method for the synthesis of oxazolidin‐2‐ones and imidazolidin‐2‐ones directly from 1,3‐diols and 3‐amino alcohols has been developed using the same reagent combination of iodobenzene dichloride (PhICl2) and sodium azide (NaN3).
    使用碘代二氯二苯甲烷(PhICl 2)和叠氮化钠的相同试剂组合,开发了一种直接,直接由1,3-二醇和3-氨基醇合成恶唑烷-2-酮和咪唑啉-2-酮的通用有效方法。(NaN 3)。
  • Melanocortin receptor ligands
    申请人:The Procter & Gamble Company
    公开号:US20040224985A1
    公开(公告)日:2004-11-11
    Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula: 1 wherein A is a conformationally restricted ring system selected from the group consisting of: a) non-aromatic carbocyclic rings; b) aromatic carbocyclic rings; c) non-aromatic heterocyclic rings; d) aromatic heterocyclic rings; wherein said rings comprises from 5 to 8 atoms; and W is a unit which preferable comprises D-1-fluorophenyalanine, Y comprises a heteroatom, and Z comprises an aromatic carbocyclic ring. Also disclosed are pharmaceutical compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 receptors.
    本发明涉及MC-3/MC-4受体配体,该配体具有以下公式:1其中A是从以下群组中选择的构象限制环系统:a)非芳香烷环;b)芳香烷环;c)非芳香杂环;d)芳香杂环;其中所述环包含5到8个原子;W是一个单元,它最好包括D-1-氟苯丙氨酸,Y包括一个杂原子,Z包括一个芳香烷环。本发明还涉及包含所述配体的制药组合物,以及通过MC-3/MC-4受体介导的治疗疾病的方法。
  • Synthesis of Natural Product-Inspired Inhibitors of <i>Mycobacterium tuberculosis</i> Mycothiol-Associated Enzymes: The First Inhibitors of GlcNAc-Ins Deacetylase
    作者:Belhu B. Metaferia、Brandon J. Fetterolf、Syed Shazad-ul-Hussan、Matthew Moravec、Jeremy A. Smith、Satyajit Ray、Maria-Teresa Gutierrez-Lugo、Carole A. Bewley
    DOI:10.1021/jm070669h
    日期:2007.12.13
    Synthesis and evaluation of a chemical library of inhibitors of the mycothiol biosynthesis enzyme GlcNAc-Ins deacetylase (MshB) and the mycothiol-dependent detoxification enzyme mycothiol-S-conjugate amidase (MCA) from Mycobacterium tuberculosis are reported. The library was biased to include structural features of a group of natural products previously shown to competitively inhibit MCA. Molecular docking studies that reproducibly placed the inhibitors in the active site of the enzyme MshB reveal the mode of binding and are consistent with observed biological activity.
  • Potent, Novel in Vitro Inhibitors of the <i>Pseudomonas </i><i>a</i><i>eruginosa</i> Deacetylase LpxC
    作者:Toni Kline、Niels H. Andersen、Eric A. Harwood、Jason Bowman、Andre Malanda、Stephanie Endsley、Alice L. Erwin、Michael Doyle、Susan Fong、Alex L. Harris、Brian Mendelsohn、Khisimuzi Mdluli、Christian R. H. Raetz、C. Kendall Stover、Pamela R. Witte、Asha Yabannavar、Shuguang Zhu
    DOI:10.1021/jm010579r
    日期:2002.7.1
    Deacetylation of uridyldiphospho-3-O-(R-hydroxydecanoyl)-N-acetylglucosamine by LpxC is the first committed step in the Pseudomonas aeruginosa biosynthetic pathway to lipid A; homologous enzymes are found widely among Gram-negative bacteria. As an essential enzyme for which no inhibitors have yet been reported, the P. aeruginosa LpxC represents a highly attractive target for a novel antibacterial drug. We synthesized several focused small-molecule libraries, each composed of a variable aromatic ring, one of four heterocyclic/spacer moieties, and a hydroxamic acid and evaluated the LpxC inhibition of these compounds against purified P. aeruginosa enzyme. To ensure that the in vitro assay would be as physiologically relevant as possible, we synthesized a tritiated form of the specific P. aeruginosa glycolipid substrate and measured directly the enzymatically released acetate. Several of our novel compounds, predominantly those having fluorinated substituents on the aromatic ring and an oxazoline as the heterocyclic moiety, demonstrated in vitro IC50 values less than 1 muM. We now report the synthesis and in vitro evaluation of these P. aeruginosa LpxC inhibitors.
  • WO2019173327A5
    申请人:——
    公开号:WO2019173327A5
    公开(公告)日:2022-03-14
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物